A method to treat conditions characterized by formation of amyloid plaques both prophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble A.beta. peptide from human biological fluids or which preferably specifically bind an epitope contained within position 13 28 of the amyloid beta peptide A.beta..